Cardiovascular-kidney-metabolic (CKM) syndrome stage is associated with impaired cardiac structure/function and increased symptom burden in patients with MASLD
Metabolic dysfunction associated steatotic liver disease (MASLD) is closely linked with cardiometabolic risk, but how cardiometabolic burden translates into early cardiac dysfunction in MASLD remains incompletely characterized. We evaluated whether higher cardiovascular-kidney-metabolic (CKM) syndrome stage was a...